Back

The influence of the daily salt-intake on the antihypertensive action and atrial natriuretic peptide level in patietns with angiotensin receptor neprilysin inhibition

31 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Hypertension: lifestyle and environment Renin-Angiotensin System ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Satoru Watanabe

Uonuma Kikan Hospital, Minamiuonuma (Japan)

6 More presentations in this session

Presentation thumbnail
Raised blood pressure affects reactivity to expressive music features
Doctor V. Pope (London, GB)
Abstract Slides Video
Presentation thumbnail
Relationship between triglyceride-to-glucose index in addition to waist circumference as a marker of insulin resistance and mean arterial pressure
Doctor H. Takami (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of muscle sympathetic nerve activity in patients afflicted with orthostatic hypertension versus conventional hypertension
Mr T. Hirai (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Epidemiological, clinical, paraclinical, evolutionary, and therapeutic aspects of hypertensive patients infected by COVID-19: about 702 patients in our city
Professor A. Ngaide (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Sleep pattern, behavior, duration and incident hypertension: results from two large prospective cohorts
Mr Z. Zheng (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension: lifestyle and environment

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy
thumbnail
Congress Presentation
Angiotensin receptor and neprilysin inhibition for the treatment of hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources